GlobeNewswire 10:00 AM BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire 10:00 AM EQIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Equinix, Inc. Investors with S...
GlobeNewswire 10:00 AM CMP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Minerals International,...
GlobeNewswire 10:00 AM ASTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AST SpaceMobile, Inc. Investor...
GlobeNewswire 10:00 AM LNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lincoln National Corporation In...
GlobeNewswire 10:00 AM ADSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Autodesk, Inc. Investors with ...
GlobeNewswire 10:00 AM Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of D...
GlobeNewswire 9:42 AM Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
TeleTrader 9:40 AM Hunt: Cannot commit to reducing prices
Newsfile Corp 9:38 AM etaily Launches in Singapore
TeleTrader 9:02 AM Spain's inflation up from 3.3% to 3.6% in May
GlobeNewswire 9:01 AM Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
TeleTrader 9:00 AM Europe opens lower as data pours in
TeleTrader 9:00 AM Swiss GDP growth at 0.5% in Q1
GlobeNewswire 9:00 AM Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire 9:00 AM Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire 8:35 AM Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
TeleTrader 8:33 AM Ukraine: 32 drones, 7 cruise missiles destroyed
GlobeNewswire 8:30 AM Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire 8:30 AM BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire 8:30 AM Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire 8:30 AM Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
TeleTrader 8:02 AM Swiss trade surplus at 3.9 billion Swiss francs in April
GlobeNewswire 8:01 AM Renewi announces sale of UK Municipal business to Biffa
TeleTrader 8:00 AM Europe lower in premarket with eyes on inflation reports